EUCTR2005-004849-33-GB进行中（未招募）1 期
Prevention of oesophagitis, gastric and duodenal lesions in patients taking antithrombotic low-dose aspirin with famotidine
HS Greater Glasgow0 个研究点目标入组 700 人开始时间: 2005年11月29日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Adult patients, aged 18 years or over, using low-dose aspirin (75-325 mg daily) for vascular protection
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Unstable or uncontrolled cardiovascular or systemic diseases. Significant endoscopic abnormalities at base-line endoscopy
研究者
相似试验
未知
2 期
ong-term administration study of E3810 for the prevention of gastric or duodenal ulcer caused by low-dose aspiriJPRN-jRCT2080221500Eisai Co., Ltd.300
未知
2 期
Efficacy of E3810 for the prevention of gastric or duodenal ulcer caused by low-dose aspiriGastric or duodenal ulcers caused by low-dose aspirinJPRN-jRCT2080221499Eisai Co., Ltd.450
招募中
不适用
Prevention of gastrointestinal complications by infusion pump in patients receiving enteral nutritioInpatients receiving enteral nutrition via nasogastric tube, gastric fistula, or intestinal fistulaJPRN-UMIN000005609Division of Clinical pharmacokinetics, Faculty of Pharmacy, Keio University200
招募中
4 期
It is the study to compare non surgical treatment modality for gastroduodenal obstructioCTRI/2020/07/026501SMS Hospital and medical college
已完成
不适用
Optimal treatment strategy for esophago-gastric junctional cancerEsophago-gastric junctional cancerJPRN-UMIN000008596Digestive Disease Center, Showa University Nothern Yokohama Hospital200